Cargando…

The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services

BACKGROUND: In addition to mandatory haematological monitoring, treatment guidelines recommend routine monitoring of adverse effects and physical health in patients prescribed clozapine. METHODS: NHS trusts/healthcare organisations participated in a clinical audit in the context of a UK quality impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Thomas R. E., MacCabe, James H., Kane, John M., Delgado, Oriana, Paton, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412922/ https://www.ncbi.nlm.nih.gov/pubmed/32821377 http://dx.doi.org/10.1177/2045125320937908

Ejemplares similares

Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit
por: Barnes, Thomas RE, et al.
Publicado: (2022)

Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring
por: Paton, Carol, et al.
Publicado: (2014)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2020)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

Clinical Audit of Clozapine Prescribing Practice and Monitoring Process in an Australian Community Mental Health Service
por: Fernando, Tharushi, et al.
Publicado: (2022)

Physical health monitoring after rapid tranquillisation: clinical practice in UK mental health services
por: Paton, Carol, et al.
Publicado: (2019)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit
por: Paton, Carol, et al.
Publicado: (2022)

The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services
por: Paton, Carol, et al.
Publicado: (2018)

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)

Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice
por: Paton, Carol, et al.
Publicado: (2016)

The side effect profile of Clozapine in real world data of three large mental health hospitals
por: Iqbal, Ehtesham, et al.
Publicado: (2020)

Side-effect monitoring of continuing LAI antipsychotic medication in UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2021)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age
por: Paton, Carol, et al.
Publicado: (2018)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Standards of lithium monitoring in mental health trusts in the UK
por: Collins, Noel, et al.
Publicado: (2010)

41.3 COULD CLOZAPINE REDUCE VIOLENT OFFENDING?
por: Bhavsar, Vishal, et al.
Publicado: (2018)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Audit of therapeutic drug monitoring of ‘clozapine plasma levels’
por: Bellam, Shakina, et al.
Publicado: (2021)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
por: Verbelen, M, et al.
Publicado: (2015)

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

Audit of Physical Health Monitoring in Long-Stay Psychiatric Inpatients on Clozapine in NHS Ayrshire & Arran
por: Carson, Chris
Publicado: (2023)

Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy
por: Segev, Aviv, et al.
Publicado: (2021)

Clozapine treatment and risk of severe COVID‐19 infection
por: Ohlis, Anna, et al.
Publicado: (2021)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine treatment and risk of COVID-19 infection: retrospective cohort study
por: Govind, Risha, et al.
Publicado: (2021)

Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy – ERRATUM
por: Segev, Aviv, et al.
Publicado: (2021)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

An audit into the physical health monitoring of patients who are prescribed antipsychotics in HMP Birmingham
por: Horton, Olivia, et al.
Publicado: (2021)

Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
por: Kadra, G., et al.
Publicado: (2018)

Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020)

Management of medically assisted withdrawal from alcohol in acute adult mental health and specialist addictions in-patient services: UK clinical audit findings
por: Sinclair, Julia, et al.
Publicado: (2023)

Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study
por: Cho, J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_23shv86ss9gt78pa7om4lfl1et